Immunome Inc. Business Finance Contracts & Agreements
16 Contracts & Agreements
- Modification Agreements (3 contracts)
- Purchase Agreements (4)
- Stock Agreements (5)
- Subscription Agreements (1)
- Underwriting Agreements (2)
- Warrant Agreements (1)
- Stock Issuance Agreement dated October 25, 2024, by and between the Company and Zentalis Pharmaceuticals, Inc (Filed With SEC on October 29, 2024)
- Asset Purchase Agreement dated October 25, 2024, by and among the Company, Zentalis Pharmaceuticals, Inc. and Zeno Management, Inc (Filed With SEC on October 29, 2024)
- Asset Purchase Agreement dated December 22, 2023, by and between the Registrant and Atreca, Inc (Filed With SEC on March 28, 2024)
- Underwriting Agreement by and among the Company, J.P. Morgan Securities LLC, Cowen and Company, LLC, Leerink Partners LLC, and Guggenheim Securities, LLC, dated February 13, 2024 (Filed With SEC on February 14, 2024)
- Asset Purchase Agreement dated February 5, 2024, by and between the Company and Ayala Pharmaceuticals, Inc (Filed With SEC on February 6, 2024)
- Form of Subscription Agreement, dated June 29, 2023 (Filed With SEC on June 29, 2023)
- Modification of Contract between the Company and the Department of Defense, United States of America, dated January 4, 2023 (Filed With SEC on March 16, 2023)
- Letter to Holders of Series B Warrants to Purchase Shares of Common Stock (Filed With SEC on September 2, 2022)
- Modification of Contract between the Company and the Department of Defense, United States of America, dated March 18, 2022 (portions of this exhibit (indicated by asterisks) have... (Filed With SEC on May 12, 2022)
- Modification of Contract between the Company and the Department of Defense, United States of America, dated May 19, 2021 (portions of this exhibit (indicated by asterisks) have... (Filed With SEC on May 20, 2021)
- Securities Purchase Agreement, dated April 26, 2021, by and among Immunome, Inc. and the Purchasers signatory thereto (Filed With SEC on April 26, 2021)
- Form of Warrant (Filed With SEC on April 26, 2021)
- 2020 Employee Stock Purchase Plan (Filed With SEC on September 24, 2020)
- Form of Amendment to 2020 Series A Preferred Stock Warrants (Filed With SEC on September 24, 2020)
- Form of Common Stock Certificate (Filed With SEC on September 24, 2020)
- Form of Underwriting Agreement (Filed With SEC on September 9, 2020)
